Cargando…
Involvement of Ca(2+)-activated K(+) channel 3.1 in hypoxia-induced pulmonary arterial hypertension and therapeutic effects of TRAM-34 in rats
Pulmonary artery hypertension (PAH) is an incurable disease associated with the proliferation of pulmonary artery smooth muscle cells (PASMCs) and vascular remodeling. The present study examined whether TRAM-34, a highly selective blocker of calcium-activated potassium channel 3.1 (Kca3.1), can help...
Autores principales: | Guo, Shujin, Shen, Yongchun, He, Guangming, Wang, Tao, Xu, Dan, Wen, Fuqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529208/ https://www.ncbi.nlm.nih.gov/pubmed/28679649 http://dx.doi.org/10.1042/BSR20170763 |
Ejemplares similares
-
Efficacy of combined tumor irradiation and K(Ca)3.1-targeting with TRAM-34 in a syngeneic glioma mouse model
por: Stransky, Nicolai, et al.
Publicado: (2023) -
Pulmonary Hypertension in Wild Type Mice and Animals with Genetic Deficit in K(Ca)2.3 and K(Ca)3.1 Channels
por: Wandall-Frostholm, Christine, et al.
Publicado: (2014) -
Modulation of Cardiovascular Function in Primary Hypertension in Rat by SKA-31, an Activator of K(Ca)2.x and K(Ca)3.1 Channels
por: Kloza, Monika, et al.
Publicado: (2019) -
The KCa3.1 blocker TRAM34 reverses renal damage in a mouse model of established diabetic nephropathy
por: Huang, Chunling, et al.
Publicado: (2018) -
The K(+) Channel K(Ca)3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis
por: Roach, Katy Morgan, et al.
Publicado: (2013)